Evidence map›Paper›PMID 30242167›Full record

ArticleScientific reports2018

Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma.

L F Araujo, A D D Siena, J R Plaça, D B Brotto, I I Barros, B R Muys, C A O Biagi, K C Peronni, J F Sousa, G A Molfetta and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Mitochondrial function meets oncology: the multifaceted role of TFAM across cancer types.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging.Frontiers in cell and developmental biology · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 3 countries.

L F AraujoDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.ORCID 0000-0002-5199-619X
A D D SienaDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
J R PlaçaNational institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil.
D B BrottoDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
I I BarrosDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
B R MuysDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
C A O BiagiDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
K C PeronniNational institute of Science and Technology in Stem Cell and Cell Therapy, Center for Cell-based Therapy-CEPID/FAPESP, Ribeirão Preto, Brazil.
J F SousaDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
G A MolfettaDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
L C WestMicrobial Pathogenesis & Immunology, Health Science Center, Texas A&M University, College Station, USA.
A P WestMicrobial Pathogenesis & Immunology, Health Science Center, Texas A&M University, College Station, USA.
A M LeopoldinoDepartment of Clinical Analysis-Toxicology and Food Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.ORCID 0000-0002-8313-4754
E M EspreaficoDepartment of Cellular and Molecular Biology-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
W A SilvaDepartment of Genetics-Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil. wilsonjr@usp.br.ORCID 0000-0001-9364-2886
Universidade de São Paulo · BRTexas A&M Health Science Center · USUniversidade de Ribeirão Preto · BR

Funding

Sensitive tumor detection with magnetomotive imagingR01CA170734 · NCI · UNIVERSITY OF WASHINGTON · PI GAO, XIAOHU · 2012 to 2015
$1.8M
Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas) RP170734Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2013/08135-2Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2013/25119-0Fundação de Amparo à Pesquisa do Estado de São Paulo (São Paulo Research Foundation) 2015/21940-7Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) 465539/2014-9
6 · The paper itself

Abstract

Mitochondria are central key players in cell metabolism, and mitochondrial DNA (mtDNA) instability has been linked to metabolic changes that contribute to tumorigenesis and to increased expression of pro-tumorigenic genes. Here, we use melanoma cell lines and metastatic melanoma tumors to evaluate the effect of mtDNA alterations and the expression of the mtDNA packaging factor, TFAM, on energetic metabolism and pro-tumorigenic nuclear gene expression changes. We report a positive correlation between mtDNA copy number, glucose consumption, and ATP production in melanoma cell lines. Gene expression analysis reveals a down-regulation of glycolytic enzymes in cell lines and an up-regulation of amino acid metabolism enzymes in melanoma tumors, suggesting that TFAM may shift melanoma fuel utilization from glycolysis towards amino acid metabolism, especially glutamine. Indeed, proliferation assays reveal that TFAM-down melanoma cell lines display a growth arrest in glutamine-free media, emphasizing that these cells rely more on glutamine metabolism than glycolysis. Finally, our data indicate that TFAM correlates to VEGF expression and may contribute to tumorigenesis by triggering a more invasive gene expression signature. Our findings contribute to the understanding of how TFAM affects melanoma cell metabolism, and they provide new insight into the mechanisms by which TFAM and mtDNA copy number influence melanoma tumorigenesis.

Indexed as

Amino AcidsCarcinogenesisCell Line, TumorDNA-Binding ProteinsDNA Copy Number VariationsDNA, MitochondrialDown-RegulationGene Expression RegulationGlutamineGlycolysisHumansMelanomaMitochondriaMitochondrial ProteinsTranscription FactorsUp-RegulationAmino AcidsDNA-Binding ProteinsDNA, MitochondrialGlutamineMitochondrial ProteinsTFAM protein, humanTranscription FactorsVascular Endothelial Growth Factor A

Identifiers

PMID30242167
PMCPMC6155108
OpenAlexW2890799860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.